Journal of diabetes science and technology
Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey.
Patient Self-Management of Diabetes Care in the Inpatient Setting: Con.
Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.
Cybersecurity for Connected Diabetes Devices.
Trends in FDA regulation of software to control insulin dosing.
Functional Evaluation of the Reusable JuniorSTAR® Half-Unit Insulin Pen.
Precision medicine for managing diabetes.
Afrezza inhaled insulin: the fastest-acting FDA-approved insulin on the market has favorable properties.
Improved insulin absorption by means of standardized injection site modulation results in a safer and more efficient prandial insulin treatment. A review of the existing clinical data.
Hospital diabetes meeting: Arlington, Virginia, May 13, 2014.
